Delivery Order SPE2DB20D2104-SPE2DB25FMJGP
Award Date
2/19/25
Potential Completion Date
2/20/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $2,048.36 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of Estrace 0.01% Cream, a prescription pharmaceutical product, to support the medical needs of U.S. government agencies and healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Estrace 0.01% Cream in 42.5 gram units. The $2,002.68 firm fixed-price delivery order is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, to provide Estrace 0.01% cream. The contract is a firm fixed price delivery order with a ceiling value of $1,736.50 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp. is the prime contractor for this award, which does not have a set-aside designation. The contract is a part of...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,442.22 firm fixed price contract is for the delivery of Estrace 0.01% cream, a prescription medication. The contract has an ultimate completion date of August 6, 2024. AmerisourceBergen has been awarded multiple federal contracts and indefinite delivery vehicles by DLA and other agencies to supply a wide range of pharmaceutical and...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) for the supply of Estradiol 0.01% cream. The contract has a ceiling value of $1,708.33 and a period of performance through April 3, 2023. Amerisourcebergen, a major pharmaceutical distributor, has a significant IDC with DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $1,620.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract involves the delivery of Estrace 0.01% Cream, a pharmaceutical product, and is a Firm Fixed Price Delivery Order without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Estrace 0.01% Cream, a pharmaceutical product, with a ceiling value of $1,331.41 and a completion date of March 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,419.85 firm fixed-price delivery order is for the supply of Estrace 0.01% cream, a topical estrogen medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,372.02 firm fixed-price delivery order is for the supply of ESTRACE 0.01% Cream, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of January 12, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The $2,425.06 firm fixed-price contract is for the delivery of Estrace 0.01% cream, a topical estrogen medication. The order has a completion date of February 23, 2022 and was awarded on February 22, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...